Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,662.7
-6.8 (-0.26%)

 

  • STI Straits Times Index
    2,662.7
    -6.8 (-0.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,584.4
    0.9 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,248.9
    119.7 (0.46%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,427.2
    23.7 (0.70%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,478.4
    39.7 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,091.2
    15.1 (0.30%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 885.9M
  • Value: 292.3M
  • Rise: 123
  • Fall: 115
  • Unch: 570

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.009+0.004
AsiaMedic0.033+0.013
Singapore-eDev0.134+0.001
3Cnergy0.021+0.004
Medtecs Intl0.895+0.075
Thomson Medical0.061+0.002
Anchor Resources0.007+0.001
Clearbridge0.182+0.010
Healthway Med0.039+0.004
SingMedical0.270+0.015

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WEIGAO GROUP WEIGAO GROUP
Quotes 15 Minutes Delayed. Updated at 09 Jul 2020 10:42
Last (HKD): 19.220 Change: +0.060 High: 19.500 Remarks: -
Change (%): +0.31 Low: 18.700
Open 19.160 Yesterday's Close 19.160
Buy Price 18.980 Sell Price 19.020
Buy Volume ('000) 16 Sell Volume ('000) 28
Cumulative Volume ('000) 6,314 Cumulative Value 120,539,120
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.46258 Trailing EPS (HKD) e 0.46258 NAV (HKD) b 4.0034
PE a 41.550 Trailing PE f 41.549 Price / NAV b 4.8009
Dividend (HKD) d 0.132893 Cash In Hand (HKD) g 1.1283 Issued & Paid-up Shares c 4,522,330,000
Dividend Yield (%) d 0.691 Price / Cash In Hand g 17.034 Treasury Shares h -
Beta - 75 Daysi 0.625 R-Squared - 75 Days(%)i 9.56 Market Cap (M) 86,919.183
Beta - 500 Daysi 0.710 R-Squared - 500 Days (%)i 12.00 Enterprise Value (M) 88,805.820
Piotroski F Score 6 Exchange Code 1066 Par Value ( CNY ) 0.10000
52 Weeks Volatility (%) 40.29 6-Month VWAP 12.987 Free Float (%) 52.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WEIGAO GROUP HKEx 86,919.183 41.550 41.549 4.8009 0.691
Industry Medical Specialties HKEx 18,188.786 115.667 115.667 6.9783 0.280
Local Peer MICROPORT HKEx 70,027.514 193.111 193.115 17.3159 0.123
Local Peer KANGJI MEDICAL HKEx 43,326.466 209.875 209.870 132.4148 -
Local Peer VENUS MEDTECH-B HKEx 34,298.963 - - 10.0964 -
Local Peer AK MEDICAL HKEx 29,297.411 96.773 96.772 23.4696 0.269
Local Peer PEIJIA-B HKEx 21,962.255 - - -39.3424 -
Local Peer KDL MEDICAL HKEx 11,744.500 103.975 103.976 8.6316 0.276
Local Peer LIFETECH SCI HKEx 9,873.185 67.397 67.393 7.6612 -
Local Peer CIRC HKEx 6,621.408 17.747 17.747 1.5746 0.738
Local Peer YESTAR HEALTH HKEx 2,733.148 11.893 11.893 2.0837 -
Local Peer PW MEDTECH HKEx 2,652.032 28.528 28.529 0.5144 -
Local Peer GOLDEN MEDITECH HKEx 2,362.713 - - 0.6145 -
Local Peer VINCENT MED HKEx 1,932.080 167.681 167.642 5.4822 0.363
Other Local Peers MODERN DENTAL (HKEx), YUNNAN ENERGY (HKEx), KELFRED (HKEx), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 163,760.133 44.670 46.273 5.4193 1.421
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 152,699.905 41.315 41.619 5.3468 0.198
Global Peer DANAHER CORP NYSE 130,651.796 52.496 47.735 4.4356 0.362
Global Peer MEDTRONIC PLC NYSE 122,876.493 25.658 25.658 2.4218 2.357
Global Peer BECTON DICKINSON & CO NYSE 71,643.648 66.214 78.729 3.4199 1.170
Global Peer STRYKER CORP NYSE 68,132.486 32.709 31.485 5.1950 1.174
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,750.393 49.119 48.871 7.9644 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 49,362.622 10.503 11.514 3.5760 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,833.814 42.791 41.953 5.5636 1.004
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,960.931 32.891 32.891 3.0382 1.910
Other Global Peers EDWARDS LIFESCIENCES CORP (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), TOPGLOV (Bursa), STERIS PLC (NYSE), Top Glove (SGX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), ATRICURE INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), CAREDX INC (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), UG Healthcare (SGX), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), Biolidics (SGX), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), Yunnan Energy (SGX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEUROTROPE INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), DIGIRAD CORP (NASDAQ), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.140
+6.31 %
10 Days -+2.860
+17.48 %
20 Days -+3.220
+20.12 %
Medium Term Return 3 Months -+8.820
+84.81 %
6 Months -+10.090
+110.51 %
1 Year 0.066+11.900
+163.47 %
Long Term Return 2 Years 0.180+13.590
+244.58 %
3 Years 0.287+13.070
+217.19 %
5 Years 0.477+14.050
+280.99 %
Annualised Return Annualised --
+30.67 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.470 - 19.600 Change From 1 Year Low +12.750 % Change From 1 Year Low (%) +197.06
Change From 1 Year High -0.380 % Change From 1 Year High (%) -1.94
2 Years Range 5.530 - 19.600 Change From 2 Years Low +13.690 % Change From 2 Years Low (%) +247.56
Change From 2 Years High -0.380 % Change From 2 Years High (%) -1.94
5 Years Range 4.220 - 19.600 Change From 5 Years Low +15.000 % Change From 5 Years Low (%) +355.45
Change From 5 Years High -0.380 % Change From 5 Years High (%) -1.94
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Jul 2020 17.620 19.600 17.620 19.160 30,409,514 18.9792
07 Jul 2020 18.380 18.500 17.220 17.600 50,647,718 17.6311
06 Jul 2020 18.700 19.000 18.280 18.400 19,964,686 18.5430
03 Jul 2020 18.360 18.920 18.220 18.700 24,997,538 18.5818
02 Jul 2020 17.540 18.180 17.320 18.080 39,319,735 17.7684
30 Jun 2020 17.400 17.900 17.240 17.240 46,310,600 17.5420
29 Jun 2020 15.900 17.540 15.900 17.400 108,312,788 16.2910
26 Jun 2020 16.180 16.400 15.940 16.280 7,507,288 16.2080
24 Jun 2020 16.060 16.560 16.060 16.360 14,829,492 16.3683
23 Jun 2020 15.360 16.120 15.200 16.060 13,500,268 15.8449
22 Jun 2020 15.520 15.700 15.260 15.300 8,678,784 15.4296
19 Jun 2020 15.140 15.680 15.000 15.520 26,903,322 15.4777
18 Jun 2020 15.600 15.620 15.120 15.260 29,631,340 15.3530
17 Jun 2020 16.400 16.400 15.760 15.820 18,396,380 15.9005
16 Jun 2020 16.300 16.480 15.740 16.000 12,258,158 15.9839
15 Jun 2020 16.840 16.840 15.640 15.700 26,502,100 15.9347
12 Jun 2020 15.960 16.680 15.320 16.680 19,990,242 16.4215
11 Jun 2020 16.100 16.440 15.980 16.000 25,832,103 16.2696
10 Jun 2020 15.860 16.620 15.780 16.080 26,870,243 16.2543
09 Jun 2020 15.500 16.040 14.520 15.860 14,607,111 15.8390
08 Jun 2020 15.540 16.060 15.160 15.580 24,450,958 15.7500
05 Jun 2020 15.400 15.700 15.080 15.400 20,979,853 15.4844
Summary
Current 2 Weeks
(23 Jun 2020 to 08 Jul 2020)
15.360 19.600 15.200 19.160 355,799,627 -
Previous 2 Weeks
(09 Jun 2020 to 22 Jun 2020)
15.500 19.600 14.520 15.300 209,669,783 -
4 Weeks from
(12 May 2020 to 08 Jun 2020)
11.820 19.600 11.780 15.580 530,062,393 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.